Iovance Biotherapeutics Inc. buy Chardan Capital
Start price
16.08.23
/
50%
€6.53
Target price
16.08.24
€26.61
Performance (%)
30.58%
Price
26.07.24
€8.52
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Iovance Biotherapeutics Inc. has seen massive gains of 30.58%. This prediction currently runs until 16.08.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | 16.416% | 16.416% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by Chardan_Capital for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $29.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Chardan_Capital for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€10.58
20.02.24
20.02.24
€31.41
20.02.25
20.02.25
-19.43%
26.07.24
26.07.24
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.49
10.08.23
10.08.23
€26.26
10.08.24
10.08.24
36.13%
26.07.24
26.07.24
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.85
01.03.23
01.03.23
€27.17
01.03.24
01.03.24
127.70%
02.03.24
02.03.24